conference reporter

2022 Genitourinary Cancers Symposium

Conference Reporter in Metastatic Prostate Cancer to Cover Key Topics Being Presented at the 2022 Genitourinary Cancers Symposium

Overview

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. This issue of Conference Reporter will feature coverage of selected topics in Metastatic Prostate Cancer presented at this year’s Genitourinary Cancers Symposium.

The clinicians who were surveyed selected the following expert commentators and topics from the previous conference.

Community-Selected Expert Commentators:

Christopher J. Logothetis, MD

Professor, Department of Genitourinary Medical Oncology
Director, David H. Koch Center for Applied Research of Genitourinary Cancers
Director, Prostate Cancer Research Program
Roy M. and Phyllis Gough Huffington Distinguished Chair in Clinical Research in Urologic Oncology
The University of Texas MD Anderson Cancer Center
Houston, TX

Judd W. Moul, MD

James H. Semans, M.D. Distinguished Professor of Urologic Surgery
Professor of Surgery
Professor in Anesthesiology
Urologic Surgery Division
Member, Duke Cancer Institute
Duke University School of Medicine
Durham, NC

Scott T. Tagawa, MD, MS, FACP

Professor of Medicine and Urology
Weill Cornell Medicine
Attending Physician
NewYork-Presbyterian/Weill Cornell Medical Center
New York, NY

Community-Selected Topics:

    Implementing Novel Targeted Radioligand Therapies
    Biomarker Testing in the Emerging Treatment Era
    Predictive and Prognostic Value of Advanced Positron Emission Tomography Imaging
    Disparities and Access to Cutting-Edge Treatments and Trials
    Treatment Decision Making: Understanding What Matters to Patients With Metastatic Castration-Resistant Prostate Cancer
    First-in-Class Prospects and New Targets in Metastatic Castration-Resistant Prostate Cancer


This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American Society of Clinical Oncology, the American Society for Radiation Oncology, or the Society of Urologic Oncology.

More in Metastatic Prostate Cancer

Thumb

Metastatic Prostate Cancer

Prostate-Specific Membrane Antigen–Targeted Therapies: Expert Insights

Conference Reporter by Peter R. Carroll, MD, MPH

Prostate-specific membrane antigen (PSMA) has emerged as a preeminent prostate cancer target for diagnostic imaging. Additionally, as seen at the 2...READ MORE

Thumb

Metastatic Prostate Cancer

High-Risk and Locally Advanced Prostate Cancer: Clinical Roundup

Conference Reporter by Peter R. Carroll, MD, MPH

Advancements in imaging and the identification of clinical and genomic risk factors are improving the treatment of patients with high-risk localize...READ MORE

Thumb

Metastatic Prostate Cancer

Treatment Sequence in Patients With Castration-Resistant Prostate Cancer

Conference Reporter by William K. Oh, MD

Strategies to sequence and combine therapies for patients with advanced prostate cancer continue to evolve as newer treatments emerge and data from...READ MORE

More In Conference Reporter